|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 欧洲新生儿呼吸窘迫综合征防治指南-2010版显示文摘呼吸窘迫综合征(RDS)是由于肺表面活性物质(PS)缺乏及肺结构发育不成熟所致,多见于早产儿,自然病程为生后当时或很快发病,并在生后2d内进行性恶化,如不及时治疗,因进行性缺氧和呼吸衰竭而死亡,存活者,在生后2—4d病情开始改善。胎龄越小,RDS发生率越高,2006年EuroNeoStat的数据显示:胎龄23~25周的早产儿RDS发生率为91%, | Sweet DG Carnielli V Greisen G Hallman M Ozek E Plavka R Saugstad OD Simeoni U Speer CP Halliday HL 袁琳(翻译) 陈超(审校) | 2011 | 中华儿科杂志2011，49，1： | 137 |
| 2 | 欧洲早产儿呼吸窘迫综合征防治共识指南(2013版)显示文摘本次指南更新包括了自2010年以来Cochrane系统评价和医学文献中的最新证据,并采纳了一种新的证据评估分级系统(GRADE)。以往关于早期肺表面活性物质和持续气道正压通气治疗的推荐目前拥有了更坚定的循证依据。对产房复苏、稳定生命体征等内容进行了较大扩充。生命体征稳定后的氧疗目前仍存在一定的争议,但是在获得更多的证据之前,血氧饱和度的目标范围不应低于90%,支持治疗对于超早早产儿仍然极为重要。指南对其他注意事项进行了缩减。 | Sweet D Carnielli V Greisen G Hallman M Ozek E Plavka R Saugstad OD Simeoni U Speer CP Halliday HL 王敏婕 袁琳 陈超 | 2014 | 中华儿科杂志2014，52，10： | 34 |
| 3 | Therapeutic management options for stage Ⅲ non-small cell lung cancer显示文摘Lung cancer is the leading cause of cancer death worldwide.Majority of newly diagnosed lung cancers are non-small cell lung cancer(NSCLC), of which up to half are considered locally advanced at the time of diagnosis.Patients with locally advanced stage Ⅲ NSCLC consists of a heterogeneous population, making management for these patients complex.Surgery has long been the preferred local treatment for patients with resectable disease.For select patients, multimodality therapy involving systemic and radiation therapies in addition to surgery improves treatment outcomes compared to surgery alone.For patients with unresectable disease, concurrent chemoradiation is the preferred treatment.More recently, research into different chemotherapy agents, targeted therapies, radiation fractionation schedules, intensity-modulated radiotherapy, and proton therapy have shown promise to improve treatment outcomes and quality of life.The array of treatment approaches for locally advanced NSCLC is large and constantly evolving.An updated review of past and current literature for the roles of surgery, chemotherapeutic agents, radiation therapy, and targeted therapy for stage Ⅲ NSCLC patients are presented. | Stephanie M Yoon Talha Shaikh Mark Hallman | 2017 | World Journal of Clinical Oncology2017，8，1： | 32 |
| 4 | Back-scattered electronimaging and elemental analysis of retrieved bone tissue followingsinus augmentation with deproteinized bovine bone or biphasiccalcium phosphate显示文摘 | Lindgren C Hallman M Sennerby L | 2010 | Clin Oral Impl Res2010，21，9： | 1 |
| 5 | Regulation of surfactant proteins by LPS and proinflammatory cytokines in fetal and newborn lung 显示文摘 | Vayrynen O Glumoff V Hallman M | 2002 | Am J Physiol Lung Cell Mol Physiol2002，282，4： | 1 |
| 6 | A mechanism of nitric oxide induced surfactant dysfunction显示文摘 | Bry K Lappalainen U | 1996 | J Appl Physiol1996，80，6： | 1 |
| 7 | Evidence of lung surfactant abnormality in respiratory failure:study of bronchoalveolar Lavage phospholipids,surface activity,phospholipase activity,and plasma myoinositol显示文摘 | Hallman M Spragg R Harrell J H | 1982 | J Clin Invest1982，70，： | 1 |
| 8 | Surfactant proteins as genetic deter-minants of multifactorial pulmonary diseases显示文摘 | Haataja R Hallman M | 2002 | Ann Med2002，34，： | 1 |
| 9 | Tumour response and radiation- induced lung injury in patients with recurrent small cell lung cancer treated with radiotherapy and concomitant interferon - alpha显示文摘 | Halme M Hallman M Ruotsalainen T | 1999 | Lung Cancer1999，23，1： | 1 |
| 10 | Histological and histomorphometrical analyses of biopsies harvested 11 years after maxillary sinus floor augmentation with deproteinized bovine and autogenous bone显示文摘 | Mordenfeld A Hallman M Johansson CB | 2010 | Clin Oral Implants Res2010，21，9： | 1 |
| 11 | Differentiating technical translation from tech nical writing 显示文摘 | Hallman M | 1990 | Technical Communication1990，，3： | 1 |
| 12 | Inflammatory pathways between placenta and foetus显示文摘 | Hallman M | 2001 | Acta Paediatr2001，90，： | 1 |
| 13 | Pattern recognition receptors and ge- netic risk for rsv infection:value for clinical decision-making显示文摘 | R/imet M Korppi M Hallman M | 2011 | Ped- iatr Pulmono12011，46，2： | 1 |
| 14 | Hyperoxia and glucocorticoid modify retinal vessel growth and interleukin-1 receptor antagonist in newborn rabbits显示文摘 | Lawas-Alejo PA Slivka S Hernandez H Bry K Hallman M | 1999 | Pediatr Res1999，45，： | 1 |
| 15 | Xenon purity analysis for exo-200 via mass spectrometry 显示文摘 | Dobi A Hall C Slutsky S Yen Y R Aharmin B Auger M Barbeau P S Benitez-Medina C Breidenbach M Cleveland B Conley R Cook J Cook S Counts I Craddock W Daniels T Davis C G Davis J Devoe R Dixit M Dolinski M J Donato K Fairbank Jr W Farine J Fierlinger P Franco D Giroux G Gornea R Graham K Gratta G Green C Hagemann C Hall K Hallman D Hargrove C Herrin S Hughes M Hodgson J Juget F Karelin A Kaufman L J Kuchenkov A Kumar K Leonard D S Lutter G Mackay D Maclellan R Marino M Mong B Montero Diez M Morgan P MUller A R Neilson R Odian A Oullivan K Piepke A Pocar A Prescott C Y Pushkin K Rivas A Rollin E Rowson P C Sabourov A Sinclair D Skarpaas K Stekhanov V Strickland V Swift M Twelker K Vuilleumier J L Vuilleumier J M Weber M Wichoski U Wodin J Wright J D Yang L | 2012 | Nuclear Instruments and Methods in Physics Research Section A: Accelerators Spectrometers Detectors and Associated Equipment2012，675，： | 1 |
| 16 | 'Surfactant protein C gene variation in the Finnish population-association with perinatal respiratory dis- ease显示文摘 | Lahti M Marttila R Hallman M | 2004 | Europen J Hun Genet2004，12，4： | 1 |
| 17 | Association between the Asp299Gly polymorphisms in the 'loll-like receptor 4 and prema- ture births in the Finnish population 显示文摘 | Hallman M Marttila R | 2002 | Pediatr Res2002，52，3： | 1 |
| 18 | Regulation of surfactant proteins by LPS and proinflammatory cytokines in fetal and newborn lung显示文摘 | VAYRYNEN O GLUMOFF V HALLMAN M | 2002 | Am J Physiol Lung Cell Mol Physiol2002，282，4： | 1 |
| 19 | Association between the Asp299Gly polymorphisms in the Toll-like receptor 4 andpremature births in the Finnish population显示文摘 | Lorenz E Hallman M Marttila R | 2002 | Pediatric Re search2002，52，： | 1 |
| 20 | PTPN22 polymorphism and anti-cyclic citrullinated peptide antibodies in combination strongly predicts future onset of rheumatoid arthritis and has a specificity of 100% for the disease 显示文摘 | Johansson M Arlestig L Hallmans G | 2006 | Arthritis Res Ther2006，8，1： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员